Literature DB >> 6325502

Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

J A Heinsimer, A O Davies, R W Downs, M A Levine, A M Spiegel, M K Drezner, A De Lean, K A Wreggett, M G Caron, R J Lefkowitz.   

Abstract

Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyrodism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared beta-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the beta-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors less than 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P less than 0.02) to the right as a result of a significant (P less than 0.01) decrease in the percent of beta-adrenergic receptors in the high affinity state from 64 +/- 22% in PHP-Ib and 56 +/- 5% in controls to 10 +/- 8% in PHP-Ia. The agonist competition curves were computer fit to a "ternary complex" model for the two-step reaction: H + R + N in equilibrium HR + N in equilibrium HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H. E., and A. S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, whereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325502      PMCID: PMC425155          DOI: 10.1172/JCI111336

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Column chromatography of human serum parathyroid immunoreactive peptides.

Authors:  A W Lindall; E T Wong
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

2.  Relationship between the beta-adrenergic receptor and adenylate cyclase.

Authors:  E M Ross; M E Maguire; T W Sturgill; R L Biltonen; A G Gilman
Journal:  J Biol Chem       Date:  1977-08-25       Impact factor: 5.157

3.  Partial gonadotrophin-resistance in pseudohypoparathyroidism.

Authors:  J I Wolfsdorf; R L Rosenfield; V S Fang; R Kobayashi; A K Razdan; M H Kim
Journal:  Acta Endocrinol (Copenh)       Date:  1978-06

4.  Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism.

Authors:  M K Drezner; W M Burch
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Thyroid dysfunction in pseudohypoparathyroidism.

Authors:  S J Marx; J M Hershman; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

8.  Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.

Authors:  L T Williams; R Snyderman; R J Lefkowitz
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Prolactin deficiency in pseudohypoparathyroidism.

Authors:  H E Carlson; A S Brickman; G F Bottazzo
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

10.  Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.

Authors:  L R Chase; G L Melson; G D Aurbach
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

View more
  4 in total

1.  Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure.

Authors:  D E Vatner; S F Vatner; A M Fujii; C J Homcy
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Effects of gestational age and cortisol treatment on ovine fetal heart function in a novel biventricular Langendorff preparation.

Authors:  Andrew J W Fletcher; Alison J Forhead; Abigail L Fowden; Will R Ford; Peter W Nathanielsz; Dino A Giussani
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

3.  Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor.

Authors:  D E Vatner; S F Vatner; J Nejima; N Uemura; E E Susanni; T H Hintze; C J Homcy
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium.

Authors:  C Devos; P Robberecht; P Nokin; M Waelbroeck; M Clinet; J C Camus; P Beaufort; P Schoenfeld; J Christophe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.